Interrater reliability and aspects of validity of the myositis damage index

Annals of the Rheumatic Diseases

Volumn 70, Issue 7, 2011, Pages 1272-1276

  Sultan, Shabina M ^a   Allen, Elizabeth ^b   Cooper, Robert G ^c   Agarwal, Sangita ^d   Kiely, Patrick ^d   Oddis, Chester V ^e   Vencovsky, Jiri ^f   Lundberg, Ingrid E ^g   Dastmalchi, Maryam ^g   Hanna, Michael G ^h   Isenberg, David A ^a  

^a UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c HOPE HOSPITAL   (United Kingdom)

^d ST GEORGE S HOSPITAL   (United Kingdom)

^e UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^f INSTITUTE OF RHEUMATOLOGY   (Czech Republic)

^g KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^h UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ACTIVITY; FEMALE; HUMAN; IDIOPATHIC DISEASE; IDIOPATHIC MYOSITIS; INTERNAL CONSISTENCY; INTERRATER RELIABILITY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MYOSITIS; MYOSITIS DAMAGE INDEX; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCHOOL CHILD; SCORING SYSTEM; VALIDITY;

ADOLESCENT; ADULT; AGED; CHILD; CROSS-SECTIONAL STUDIES; DERMATOMYOSITIS; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOSITIS; OBSERVER VARIATION; POLYMYOSITIS; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX;

EID: 79957644229     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/ard.2010.142117     Document Type: Article

References (12)

1. Sultan SM, Ioannou Y, Moss K, et al. Outcome in patients with idiopathic inflammatory myositis: morbidity and mortality. Rheumatology (Oxford) 2002;41:22-6. (Pubitemid 34537916)
2. Clarke AE, Bloch DA, Medsger TA Jr, et al. A longitudinal study of functional disability in a national cohort of patients with polymyositis/ dermatomyositis. Arthritis Rheum 1995;38:1218-24.
3. Miller FW, Rider LG, Chung YL, et al. Proposed preliminary core set measures for disease outcome assessment in adult and juvenile idiopathic inflammatory myopathies. Rheumatology (Oxford) 2001;40:1262-73.
4. Isenberg DA, Allen E, Farewell V, et al. International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset disease. Rheumatology (Oxford) 2004;43:49-54.
5. Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med 1975;292:344-7.
6. Gladman D, Ginzler E, Goldsmith C, et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 1996;39:363-9. (Pubitemid 26085211)
7. Sultan SM, Allen E, Oddis CV, et al. Reliability and validity of the myositis disease activity assessment tool. Arthritis Rheum 2008;58:3593-9.
8. Shrout PE, Fleiss JL. Intraclass correlations: uses in assessing rater reliability. Psychol Bull 1979;86:420-8.
9. Allen EJ, Farewell VT. The use of variance components for the assessment of outcome measures in rheumatology. J Appl Stat 2011;38:145-59.
10. Stoll T, Seifert B, Isenberg DA. SLICC/ACR Damage Index is valid, and renal and pulmonary organ scores are predictors of severe outcome in patients with systemic lupus erythematosus. Br J Rheumatol 1996;35:248-54.
11. Gladman DD, Urowitz MB, Goldsmith CH, et al. The reliability of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index in patients with systemic lupus erythematosus. Arthritis Rheum 1997;40:809-13. (Pubitemid 27199995)
12. Stoll T, Stucki G, Malik J, et al. Association of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index with measures of disease activity and health status in patients with systemic lupus erythematosus. J Rheumatol 1997;24:309-13. (Pubitemid 27104094)